24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

Leukemia Industry, October 2014 Market Reports from Top Publishers

You might be interested in: flow cytometry, hematology, therapeutics, more »


 
1-10 of about 100 reports for Leukemia

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Sections may be missing if data is unavailable for the company list of tables the leukemia & lymphoma society, inc., Key information the leukemia & lymphoma society, inc., Major ...

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Modifying enzymes, and others. The company partners with celgene, glaxosmithkline, eisai, the leukemia & lymphoma society and multiple myeloma research foundation. Epizyme is headquartered in cambridge, massachusetts ...

Hairy Cell Leukemia - Pipeline Review, H2 2014

Hairy Cell Leukemia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of hairy cell leukemia- the report reviews key pipeline products under drug profile section which includes, product description, moa and r ...

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

... Therapeutic landscape of refractory chronic lymphocytic leukemia (cll)- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2014 Update

Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Releases the only comprehensive genomic test to diagnose & stratify the most common form of leukemia (cll) 31jun 03, 2014: cancer genetics, inc. Partners with leading southwest gynecological pathology ...

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

... For the indicated disease.Scope- the report provides a snapshot of the global therapeutic landscape of acute lymphocytic leukemia (all, acute lymphoblastic leukemia)- the report reviews key ...

Seegene, Inc. (096530) - Product Pipeline Analysis, 2014 Update

Seegene, Inc. (096530) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • August 2014
  • by Global Data

... Product description 55seeplex influenza a/b onestep typing - product status 56seeplex influenza a/b onestep typing - product description 56seeplex leukemia aml1/eto ace assay - product status ...

Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Deals by valuemost active prostate cancer partnering companies11. leukemialeukemia partnering in numberstop leukemia partnering deals by valuemost active leukemia partnering companies ...

Leukemia Partnering 2009-2014

Leukemia Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Links to online copies of actual leukemia deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available. Contract documents provide ...

Acute and Chronic Myelogenous Leukemia Partnering 2009-2014

Acute and Chronic Myelogenous Leukemia Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... And chronic myelogenous leukemia partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends ...

About 1 200 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

9 Companies for Leukemia

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Celgene Corp.

United States

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.